| Name | Title | Contact Details |
|---|
OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, we have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology. The first product is for assessing the severity of prostate cancer. Other oncology indications as well as non-oncology indications are part of our pipeline. The assay is based on examining specific transcription levels between phagocytic and non-phagocytic cells. This proprietary technology and algorithm has allowed us to not only detect disease but to also, and more importantly, guide the physician as to the grade and aggressiveness of the disease. Our mission is to provide clinicians with quantifiable results that allows professionals to make timely and much more directed medical decisions.
CHCS Services, Inc. is a leading administrator of senior market insurance and eldercare programs. With a wealth of experience in the Medicare Supplement and long term care markets, our senior management team is dedicated to ensuring that CHCS Services
URAC is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
USLAB is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sport is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.